ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000664.1|Isorenieratene_1 # 1 # 1242 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000664.1|Isorenieratene_1 	1	1242	+	Loose	760	27.7202	tet(X3)	40.0	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCCCGCCGACTTCGACGTCGTGATCGTGGGAGCGGGCGCGGCCGGGATGAGCCTGGCGTACCACCTCTGCGCACCGGGCGCCGACGTACCCGTGTCGGTCGCCCTCGTCGACGCCCCGCCGGGGCCTCTGCGGGCGCCCCCGCGGACCTGGTGCTTCTGGGAGCCGCCGGGCGGGCCCTACGATCAGAGCCTGGCCGCTTCCTGGCCCCGGCTGCGGATCCGGGCGGCCGACGGAGCCGCCACGGTGGCCCGGCTCTCACGGCTGCGCTACAAGATGCTGTGCTCGGACGCTTTCGAGGCGCTGGTCGAGCGACGGCTCGCCCGCGCACCGCGCCTGTGCCGGATGGAAGCGACCGCGAGCGCCGTACGCGACGACCCGTCCGGCGCCCGCGGTGAGGTCCTGACCCGGGGCCCGGGCGGGGAACGCGTCCTCGTGACCGGCCGTCTCGTCTTCGACTCCCGGCCGCCCCGCCGCCTGCCGCCCGCCCGTACGACGCTGCTGCAGCATTTCACCGGCTGGTTCGTCCGCACCGGGCGTCCCGTGTTCGACCCGGCGACCGCGGACCTGATGGACTTCCGCACACCGCAGCCCGCGCGCGGGCTCTCGTTCGGCTACGTCCTGCCGCTGGACCCGCGCACCGCGCTGGTCGAGTACACCGAGTTCTCACCCGCCCCGCTGGACACCGACGGCTACCGGCGAGCCCTGGACCACTACACCCACGACGTGTTGGGGATCGGGCCGTTCGACGTCACGGCGCGGGAGCACGGCGTCATCCCCATGACGGACGGGCGCTTCCCGCTCAGGCAGGGGCGTTCGGTGTACCGCATCGGCACCGCCGGAGGCGCGACCCGCCCGTCGACCGGCTACACCTTCGCGGCCGTGCAGCGACAGACCCGGTACATCGCCGGCCGGTTGCGCTCCGGACGCCCGCTGCGCGTGCCCACCCCGTACGGGCGGCGGGCGCGGATGATGGACGCCGTGCTGCTGCGGGCCCTGGACAGCGGCAGGGTGGACGGCGCGGACTTCTTCGACCGCCTCTTCCGGGGCGTTCCCGGTGAGCGGCTGCTGCGCTTCATGGACGGCGGCTCGCCACCGCACGAGGACCTGCTCATCGGCCTGCGGACTCCGGTGGTCCCCATGCTGCGGACCGTCGTCGAACTCCCTTTCCGACCCCGGCGGGAACACCCGGCGCCCCCGCTCGCCCCCTCATCGACCGACACCGAGGAGAGCACCCCATGA	VPADFDVVIVGAGAAGMSLAYHLCAPGADVPVSVALVDAPPGPLRAPPRTWCFWEPPGGPYDQSLAASWPRLRIRAADGAATVARLSRLRYKMLCSDAFEALVERRLARAPRLCRMEATASAVRDDPSGARGEVLTRGPGGERVLVTGRLVFDSRPPRRLPPARTTLLQHFTGWFVRTGRPVFDPATADLMDFRTPQPARGLSFGYVLPLDPRTALVEYTEFSPAPLDTDGYRRALDHYTHDVLGIGPFDVTAREHGVIPMTDGRFPLRQGRSVYRIGTAGGATRPSTGYTFAAVQRQTRYIAGRLRSGRPLRVPTPYGRRARMMDAVLLRALDSGRVDGADFFDRLFRGVPGERLLRFMDGGSPPHEDLLIGLRTPVVPMLRTVVELPFRPRREHPAPPLAPSSTDTEESTP	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	106.44	gnl|BL_ORD_ID|4801|hsp_num:0	3401			42	132	tigecycline; tetracycline
BGC0000664.1|Isorenieratene_2 # 1239 # 1967 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.757	BGC0000664.1|Isorenieratene_2 	1239	1967	+	Loose	225	28.4906	Erm(41)	29.31	3000603	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCCTGTTGCGCGGTGACGCACTGTCCGAGGCCTTCGACCACGGCTCCGCCGCCTACGACCGCCTCGTCGCGGCCAGCCCCGGCTACCACGCGCACCTGCGCCGCTCCGCACGCCGACTGGGCCTGCCCGAGGGGGGACGCGGGCTGCGCGTGCTCGACCTGGGATGCGGCACGGGCGCCTCCACGGCCGCGCTTCTCGCCGCCGCCCCGCTCGCCCGGATCACCGGGGTCGACGCGTCCGCGGGCATGCTGGCCCGGGCGACGGCCAAGAGCTGGCCGCAGGGCGTCGACTTCGCCCACCACCCGGTCGAGGAGCTGGCCGGACGGCTGGAAGCCGGTTCCTTCGACGCGGTGTTCGCCGGATACCTCTTCCGCAACCTCGCCGACCCCGACCAGGCCCTCGACCTGGTGCGCGGTCTGCTCGTCCCCGGTGGCCGGCTCGCCGTCCACGAGTACACGCTCGGCGGTTCCCCCGCCCACCTGGCCGCGTGGAGGACGATCTGCTCCCTGATCATCCAGCCGGCCGGCCGGCTCGCCGGGGACGCCGGCCTCTACCGACACCTCCGGGACAGCGTCACCCGGTTCGACACGGCTCCCGCGTTCGCCCGGCGGCTGCGCCGGGCCGGCTTCACCGACGTACGCGTGCTCCCGCTGCCCGGCTGGCAGACCGGCATCACGCACACCTTCGTCGCCCGCACCGCCGCCGGCCCGGGGGGACGGGCATGA	MTLLRGDALSEAFDHGSAAYDRLVAASPGYHAHLRRSARRLGLPEGGRGLRVLDLGCGTGASTAALLAAAPLARITGVDASAGMLARATAKSWPQGVDFAHHPVEELAGRLEAGSFDAVFAGYLFRNLADPDQALDLVRGLLVPGGRLAVHEYTLGGSPAHLAAWRTICSLIIQPAGRLAGDAGLYRHLRDSVTRFDTAPAFARRLRRAGFTDVRVLPLPGWQTGITHTFVARTAAGPGGRA	MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR	175.36	gnl|BL_ORD_ID|1855|hsp_num:0	2013			0	309	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000664.1|Isorenieratene_3 # 1964 # 3520 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.747	BGC0000664.1|Isorenieratene_3 	1964	3520	+	Loose	750	33.4982	tet(X)	29.85	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGATGCTCCGGCGGGACGGCGACGGGGGGCACCGGCACGGGCGGGACCGGCGGGCGGAGGTCGTTCCGGCCCCGGCCGGCCGTGCCCGGTTCACGGGGGACGCCCCCGCGGTGGCGGTCGTCGGCGGCGGCATCGCGGGGATCGCGGCGGCCACCCTGCTGGCCGAACGCGGAGCACGCGTCACTCTCCACGAGAGCGAAGAGGGCCTCGGCGGGAGGCTGGCGGGGTGGCCCACCCGCCTCGCCGACGGCACCACGGTGACGATGAGCCGAGGGTTCCACGCGTTCTTCCGGCAGTACTACAACCTGCGCGGACTGCTGCGTCGGGTCGACCCCGGCCTCGGATCCCTGACCCGGCTGCCCGACTATCCGCTGCGGCACAGCTCCGGCCTGCGGGACGGCTTCGCCCGGGTGCCGCGCACGCCTCCGCTCAGCGCCCTGGGATTCGTCGCCCTCAGCCCCACCTTCGGTCCCGGGGACCTGGTCCGGATGAACCCGAGGGCGGCTCTGGGGCTGCTCGACGTGCGGGTGCCCGAGGTCTACGAACGGCTCGACGGGATCAGCGCCACCGACTTCCTCCACCGCATCCGCTTCCCGGAGGCCGCCCACCACCTGGCCTTCGAGGTCTTCTCCCGCAGTTTCTTCGCCGACCCGCGTGAACTGTCCGCTGCCGAACTGGCGCTGATGTTCCACATCTACTTCCTCGGCTCCGCCGAGGGCCTGATCTTCGACGTGCCCCGCGAACCGTTCCCCGCGGCCCTGTGGGACCCGCTCCACCGCTACCTGGAAGGGCACGGCGTCGACGTACGGACACGGACGCCGGTCCGCGAGGTCCGCCCCCTGCCCGAGGGCGGGGCGGTCCTCACGACGGACGACCTGACCACGCGGTACGACGCCCTCGTCCTGGCCCTGGACAGCGGTGGACTGCGCCACCTCGTCGCCGCGTCCCCCGAGTTGGGCGACGCCGACTGGCGGGACCGGATCGCCCGGCTGCGCACCGCCCCGCCCTTCCTGGTCTCACGGCTCTGGCTCGACCGGCCCGTGGCGCACGACCGGCCGGGGTTCCTGGGCACCAGCGGCTACGGCCCGCTGGACAACGTCAGCGTCCTCGACCGCTGGGAGGGAGAGGCCGCCCGCTGGGCCCGGCGCACGCGGGGCTCGGTCGTCGAACTGCACGCCTACGCCGTCGCACCGGACGCCGACCGGGCCGCCGTACAGGCCGAGACGCTCGGGCAACTGCACCGCGTCTACCCGGAGACCCGGAGCGCCCGGCTCCTGGACGAGCGTCACGAGTGGCGGGCGGACTGCCCCATGTTCCCGGTCGGCGGCTACCGGGACCGGCCCGGTGTGCGCAGCCCCGACCCCACGGTCACCGTGGCCGGGGACATGGTCCGCACCGGGCTGCCCGTGGCTCTGATGGAACGAGCGGCCACCAGCGGATTCCTCGCCGCGAACGCCCTGCTGGAGCGCTGGGGCGTACGCGGGCAGACGCTCTGGACCGTGCCGCGCGCGGGGCGGTCGGCCGTCCTGCGCAGGCTCGCCGCGCTGGCCGACTGA	MMLRRDGDGGHRHGRDRRAEVVPAPAGRARFTGDAPAVAVVGGGIAGIAAATLLAERGARVTLHESEEGLGGRLAGWPTRLADGTTVTMSRGFHAFFRQYYNLRGLLRRVDPGLGSLTRLPDYPLRHSSGLRDGFARVPRTPPLSALGFVALSPTFGPGDLVRMNPRAALGLLDVRVPEVYERLDGISATDFLHRIRFPEAAHHLAFEVFSRSFFADPRELSAAELALMFHIYFLGSAEGLIFDVPREPFPAALWDPLHRYLEGHGVDVRTRTPVREVRPLPEGGAVLTTDDLTTRYDALVLALDSGGLRHLVAASPELGDADWRDRIARLRTAPPFLVSRLWLDRPVAHDRPGFLGTSGYGPLDNVSVLDRWEGEAARWARRTRGSVVELHAYAVAPDADRAAVQAETLGQLHRVYPETRSARLLDERHEWRADCPMFPVGGYRDRPGVRSPDPTVTVAGDMVRTGLPVALMERAATSGFLAANALLERWGVRGQTLWTVPRAGRSAVLRRLAALAD	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	133.51	gnl|BL_ORD_ID|763|hsp_num:0	776			54	249	tigecycline; tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000664.1|Isorenieratene_4 # 3556 # 4572 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.756	BGC0000664.1|Isorenieratene_4 	3556	4572	-	Loose	650	27.335	adeL	44.83	3000620	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCCCGGCGGCGGGACGCCCGCGATCCGGCCGGCTGCCCCTGCGGGTGCGGCGTGCGCCCGTCCCGTGGGAGCGTCAGGCGCCCACCTGGCGCGCGGCGCGGCCCTCGGTCATCGCGGAGGCCCTGAAGCGTGCGCGGAGCAGGCCTTCCGGCAACTGGTACGTCATCGGCGCCTCGCGGGCCCTTCCTCCCGGGAAGGTCCTCGGGGTCACGGTCGGCTCGACCGAGGTGGTGGCGTGGCGCGACGAGGAGGGAAGGCTGCGCACCGGTCCGGGCGCGTGCCCGCATCTGGGGGCGCCGCTGCGCGACAGTCCCGTCCGCTGCGGCACCCTGGTCTGCCACTGGCACGGACTCGCGCTCGACGGCGGGCCGTTCGCCGGATGGGAGCCCTATCCCGCCTTCGACGACGGGGTCCTGCTCTGGGTGCGGCTCGACCGGGAGGGGGGTGAGCCCCCTTCACAACGTCCCCGCGTACCCTCCCGGCCGAGGGTTCGGGACGCCGTGGAGGCGGTCTACTGCGGCGTGGGCCGTTGTGAGCCGGAGGACGTGGTGGCCAACCGCCTCGATCCGTGGCACGGGGCGTGGTTCCACCCGTACTCCTTCGTGGACCTGACGGTGACGGGCACGCCCGAGGACGGCCCGGCGGACGGCGACGGGTTCACCGTCGACGTGTCCTTCAAGGTGGCCGGGCGCCTGGTGGTGCCCGTCCGGGCCCGGTTCACGGCGCCCGGGCCCCGTACGGTCGTCATGCACATCGTCGAGGGCGAGGGCGCGGGGTCCGTCGTGGAGACCCACGCCACCCCCCTCGCTCCGGACCGGTGGGGCAAGCCGCGCACGGCGGTGACGGAGGCCCTGGTCGCGGCCTCGGACCGTCGCGGATTCGCCGTGGCCCGGGCGGCGGCTCCGCTGTTGCGTCCCCTGATGCGCGCCTCGGCCGGCCGCTTGTGGCGGGACGACCTGGCGTACGCGGAGAGGCGCTGGGAACTCCGCGACCGCGGGACGTTCCCCGGCTGA	MSPAAGRPRSGRLPLRVRRAPVPWERQAPTWRAARPSVIAEALKRARSRPSGNWYVIGASRALPPGKVLGVTVGSTEVVAWRDEEGRLRTGPGACPHLGAPLRDSPVRCGTLVCHWHGLALDGGPFAGWEPYPAFDDGVLLWVRLDREGGEPPSQRPRVPSRPRVRDAVEAVYCGVGRCEPEDVVANRLDPWHGAWFHPYSFVDLTVTGTPEDGPADGDGFTVDVSFKVAGRLVVPVRARFTAPGPRTVVMHIVEGEGAGSVVETHATPLAPDRWGKPRTAVTEALVAASDRRGFAVARAAAPLLRPLMRASAGRLWRDDLAYAERRWELRDRGTFPG	MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	100.30	gnl|BL_ORD_ID|2315|hsp_num:0	2654			12	99	tetracycline
BGC0000664.1|Isorenieratene_5 # 4569 # 5597 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.752	BGC0000664.1|Isorenieratene_5 	4569	5597	-	Loose	500	26.9498	FEZ-1	25.93	3000606	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	FEZ beta-lactamase	ATGACCGTCCGCGAACTCGACGCCGCAGGCATCCACGACCCCGCGCTCCGGGCCGCGTACACCCGCTGCCGCGTTCTCAACGCACGTCACGGCAGGACCTACTTCCTCGCGACACGGCTCCTCCCCGTCGACCGCCGTCCCGCCGTCCACGCCCTGTACGGCTTCGCCCGCCGCGCCGACGACATCGTCGACGATCTCGACAGCAGCGCCACACCGGGGGAACGCGCCCGCGCCTTGCTCGACCTGGAGGCCCGGCTGGAGGCGGGGCTGCGGGGGGCCCCGGCCGCCGAGCCGGTGATCCGTGCCCTGGCCGACACGGCGGGCCGGTACGCCATCGACCATCGCCACTTCACCGATTTCCTCCGCTCCATGCGGAGCGACCTGACCGTCGGCGGCTATGCCTCGTACGAGGAACTCGGCCGGTACATGCACGGCTCGGCCGCGGTGATCGGCCTTCAGATGCTGCCGGTGCTGGGGACGGTGGTGCCGCGCGAGGAAGCGGCGCCGCACGCGGCCGCGCTCGGTGTCGCCTTCCAGCTGACCAACTTCCTGCGGGACGTGGGTGAGGACCTGGACCGGGGACGGCTCTACCTGCCGACCGAGCTGCTGGCCGCGCACGGGGCGGACCGCGAACGGTTCGAGTGGAGCCGGAACACGGGGGTGCGGGACAGCCGGATCAGGGAGGTCGTGCGGGCCGCCGCGGCACACAACCGAACCGTCTACCGGGCCGCCCTGCCCGGCATCTCCCTGCTCGCCCCGGTGTCGCGGCCCTGCATCCGTACGGCGTTCGTGCTGTACAGCGGCATCCTCGACGCGATCGAGGCGGACGGGTACGCGGTCCTGCACCGCCGGGCGGTCGTCCCGCGCCGACGCCGGGCGGCCGTGGCGCTGGACGGTCTGGTGCGGGCGGTCGCCGTGCGCACGGTGGGCCGGCGCCGGGCGGACGCGATGGCGGCGGCCCGGCCCGCCGAGCCGTCCCGGCCGCGGGAGGTCGGCGCCCCGGCCCCGGTGCGGGAGGAGGCCGTATGA	MTVRELDAAGIHDPALRAAYTRCRVLNARHGRTYFLATRLLPVDRRPAVHALYGFARRADDIVDDLDSSATPGERARALLDLEARLEAGLRGAPAAEPVIRALADTAGRYAIDHRHFTDFLRSMRSDLTVGGYASYEELGRYMHGSAAVIGLQMLPVLGTVVPREEAAPHAAALGVAFQLTNFLRDVGEDLDRGRLYLPTELLAAHGADRERFEWSRNTGVRDSRIREVVRAAAAHNRTVYRAALPGISLLAPVSRPCIRTAFVLYSGILDAIEADGYAVLHRRAVVPRRRRAAVALDGLVRAVAVRTVGRRRADAMAAARPAEPSRPREVGAPAPVREEAV	MKKVLSLTALMMVLNHSSFAYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFKFSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFTQSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPGYKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLQKGQNNPFVDPTGCKNYIEQKANDFYTELKKQETA	121.28	gnl|BL_ORD_ID|300|hsp_num:0	322			477	720	
BGC0000664.1|Isorenieratene_6 # 5594 # 7117 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.749	BGC0000664.1|Isorenieratene_6 	5594	7117	-	Loose	1000	33.4982	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide	35.71	3005106	protein variant model	D58G	D58G:3836	thioamide antibiotic	antibiotic target alteration	prothionamide resistant ethA	GTGATCACGGTCAAGGGGCGCGTCGACCACGTGGTGGTGGTCGGCGCCGGTCTGGCGGGGCTGTCCGCCGCGCTGCACCTGCTGGGCGCCGGCCGCCGGGTGACGGTCGTCGAGCGGGAGAGCCTGCCCGGGGGCCGGGCCGGGCTGCTGGAATCGGGCGGCTTCCGTATCGACACCGGGCCGACCGTGCTGACGATGCCGGACCTGGTGGAGGAGGCCTTCGCCGCGGTCGGGGAGGCGACGGCCGACCGCTTGGAGCTGATCAGGCCCGCCCCCGCCTACCGGGCCCGGTTCGCCGACGGGTCCCGGCTCGACGTGCACACCGACGGCGCCGCGATGGAGGCAGCCGTCGAGGAGTTCGCGGGGGCCCGGCAGGCGGCCGGCTACCGGCGGCTGAGGATCTGGCTGGAGCGCCTCTACCGGGCGCAGATGCGCCGTTTCATCGACACCAACTTCGACTCACCGCTCCAGCTCGCCCATCCGGACCTGGCCCGCCTCGCGGCGCTCGGCGGTTTCGGCCGGCTCGACGCGCGGATCGGGCACTTCGTCTCCGACGAACGGCTGCGCAGGGTCTTCTCCTTCCAGGCGCTGTACGCGGGCGTGCCGCCGGCCCGGGCGCTGGCCGCTTACGCGGTGATCGCCTACATGGACACGGTGGCCGGGGTGTACTTCCCCCGGGGCGGTATGCACGCGCTGCCCCGGGCGATGGCGGACGCCGCCGCGGACGCCGGCGCCTCCCTCCGCTACGGGCGGAGCGTGACCCGGCTGGAGCGGTCGGGTGACCGGGTCACCGCCGTCGTCACGGACCAGGAGCGCATTCCGTGCGACGCGGTCGTGCTGACCCCTGATCTCCCGGTCAGCTACCGGCTGCTCGGCCGGAGCCCGCGCCGCCCCCTGCCGCTGCGACATGCGCCGTCCGCGGTGATCCTGCACGCGGGCACGGACCGCACCTGGCCGGAGCTGGCGCACCACACCATCTCGTTCGGCGCGGCCTGGAAGGGCACCTTCCACGAGCTCACCCGCGCCGGGAAGCCGATGTCGGACCCCTCGCTCCTCATCACCCGGCCCACGGCGAGCGACCCCTCCCTCGCGCCGCCGGGCAAACACCTCCACTACGTGCTGGCTCCCTGCCCGAACACCGAGGTCGGGCCCGGCGTACGGGAGTGGCGGGAGCTGGGACCCCGCTACCGGGACCAGCTGGTGGCCGAACTGGAGCGCCGCGACATGCCCGGTCTCGGCGCGGCGATCGAGGAGGAGGTGCTGGTCACGCCGGTCGACTGGACCGCGCAGGGGCATGCGGCGGGCACCCCCTTCTCCGTGGCCCACACCTTCCCCCAGACCGGCCCCTTCCGGCCGCGCAACCTGGTGCGGGGCACGGCCAACGCCGTCCTCGCCGGTTGCGGCACCACACCCGGTGTCGGCGTGCCGACCGTCCTGATCTCCGGGAAGCTGGCGGCGGAGAGGATCACCGGCCCCCGCGCCACCCGCACCCCGCGCCCCACCCCGGGAGGTTCCCCCGCATGA	MITVKGRVDHVVVVGAGLAGLSAALHLLGAGRRVTVVERESLPGGRAGLLESGGFRIDTGPTVLTMPDLVEEAFAAVGEATADRLELIRPAPAYRARFADGSRLDVHTDGAAMEAAVEEFAGARQAAGYRRLRIWLERLYRAQMRRFIDTNFDSPLQLAHPDLARLAALGGFGRLDARIGHFVSDERLRRVFSFQALYAGVPPARALAAYAVIAYMDTVAGVYFPRGGMHALPRAMADAAADAGASLRYGRSVTRLERSGDRVTAVVTDQERIPCDAVVLTPDLPVSYRLLGRSPRRPLPLRHAPSAVILHAGTDRTWPELAHHTISFGAAWKGTFHELTRAGKPMSDPSLLITRPTASDPSLAPPGKHLHYVLAPCPNTEVGPGVREWRELGPRYRDQLVAELERRDMPGLGAAIEEEVLVTPVDWTAQGHAAGTPFSVAHTFPQTGPFRPRNLVRGTANAVLAGCGTTPGVGVPTVLISGKLAAERITGPRATRTPRPTPGGSPA	MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMYTLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVVIGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRWKNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGDLFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQVDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVERPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRFAKRPAPVGV	103.68	gnl|BL_ORD_ID|2821|hsp_num:0	3837			18	186	prothionamide
